222 related articles for article (PubMed ID: 8928363)
21. Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
Lowe BA
Urol Clin North Am; 1993 Feb; 20(1):75-83. PubMed ID: 8381999
[TBL] [Abstract][Full Text] [Related]
22. Late relapse (>2 years) on surveillance in stage I non-seminomatous germ cell tumours; predominant seminoma only histology.
Nolan L; Wheater M; Kirby J; Simmonds P; Mead G
BJU Int; 2010 Dec; 106(11):1648-51. PubMed ID: 20735393
[TBL] [Abstract][Full Text] [Related]
23. [Relapses of malignant nonseminomatous germinal testicular tumors].
Piot G; Droz JP; Caillaud JM; Bellet D; Wibault P; Brulé G; Amiel JL
J Urol (Paris); 1983; 89(1):49-51. PubMed ID: 6302168
[TBL] [Abstract][Full Text] [Related]
24. [Chemo-radiotherapeutic treatment of non-seminoma germ cell tumors of the testis in the advanced stage].
Krengli M; Pastore G; Invernizzi A; Maffei S
Minerva Med; 1987 Feb; 78(4):209-13. PubMed ID: 3031548
[TBL] [Abstract][Full Text] [Related]
25. [Adjuvant treatment for stage I of testicular germ cell tumours].
Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
[TBL] [Abstract][Full Text] [Related]
26. Minimizing treatment without compromising cure with primary surveillance for clinical stage I embryonal predominant nonseminomatous testicular cancer: a population based analysis from British Columbia.
Al-Tourah AJ; Murray N; Coppin C; Kollmannsberger C; Man A; Chi KN
J Urol; 2005 Dec; 174(6):2209-13, discussion 2213. PubMed ID: 16280765
[TBL] [Abstract][Full Text] [Related]
27. Management of Stage II testicular seminoma over a period of 40 years.
Detti B; Livi L; Scoccianti S; Gacci M; Lapini A; Cai T; Meattini I; Mileo AM; Iannalfi A; Bruni A; Biti G
Urol Oncol; 2009; 27(5):534-8. PubMed ID: 18848787
[TBL] [Abstract][Full Text] [Related]
28. [The clinical treatment analysis of 176 cases of testicular germ cell tumor].
Zhang P; Zeng H; Lu YP; Yuan Y; Li H
Zhonghua Nan Ke Xue; 2006 Mar; 12(3):237-9. PubMed ID: 16597041
[TBL] [Abstract][Full Text] [Related]
29. [Non-surgical treatment of testicular cancer: guidelines for the urologist].
Páez Borda A; Llorente Abarca C; Herrero Payo A; Acebal Lucia J; Berenguer Sánchez A
Actas Urol Esp; 1993 Apr; 17(4):226-33. PubMed ID: 8393610
[TBL] [Abstract][Full Text] [Related]
30. [Is risk-oriented therapy in stage I non-seminoma tumor advisable?].
Krege S; Rübben H
Urologe A; 1993 May; 32(3):171-5. PubMed ID: 8390119
[TBL] [Abstract][Full Text] [Related]
31. [Differentiated teratoma as late recurrence of metastatic non-seminomatous testicular germ cell tumor. Case report and clinical problems].
Kuczyk MA; Bokemeyer C; Fichna B; Truss M; Schmoll HJ; Jonas U
Urologe A; 1995 Nov; 34(6):480-4. PubMed ID: 8848861
[TBL] [Abstract][Full Text] [Related]
32. Patients with non-seminoma germ cell tumours treated in a minor oncology department: the importance of multi-institutional protocols and research collaboration.
Kildahl-Andersen A; Erke MG; Sagstuen H; Bremnes RM
Acta Oncol; 2005; 44(6):537-44. PubMed ID: 16165912
[TBL] [Abstract][Full Text] [Related]
33. Is there still a place for lymphadenectomy in clinical stage I non-seminoma?
Weissbach L; Boedefeld EA; Bussar-Maatz R; Kleinschmidt K
Prog Clin Biol Res; 1988; 269():407-17. PubMed ID: 2839848
[No Abstract] [Full Text] [Related]
34. Stage II testicular seminoma: patterns of recurrence and outcome of treatment.
Chung PW; Gospodarowicz MK; Panzarella T; Jewett MA; Sturgeon JF; Tew-George B; Bayley AJ; Catton CN; Milosevic MF; Moore M; Warde PR
Eur Urol; 2004 Jun; 45(6):754-59; discussion 759-60. PubMed ID: 15149748
[TBL] [Abstract][Full Text] [Related]
35. What is the appropriate follow-up after treatment?
Sharir S; Foster RS; Donohue JP; Jewett MA
Semin Urol Oncol; 1996 Feb; 14(1):45-53. PubMed ID: 8833389
[TBL] [Abstract][Full Text] [Related]
36. Medical options in the management of stages 1 and 2 (N0-N3, M0) testicular germ cell tumors.
Oliver RT; Freedman LS; Parkinson MC; Peckham MJ
Urol Clin North Am; 1987 Nov; 14(4):721-30. PubMed ID: 2823441
[TBL] [Abstract][Full Text] [Related]
37. Retroperitoneal lymph node dissection in patients with high risk testicular cancer.
Williams SB; McDermott DW; Dock W; Bahnson E; Berry AM; Steele GS; Richie JP
J Urol; 2009 May; 181(5):2097-101; discussion 2101-2. PubMed ID: 19286227
[TBL] [Abstract][Full Text] [Related]
38. Relapse-free and overall survival in patients with pathologic stage II nonseminomatous germ cell cancer treated with etoposide and cisplatin adjuvant chemotherapy.
Kondagunta GV; Sheinfeld J; Mazumdar M; Mariani TV; Bajorin D; Bacik J; Bosl GJ; Motzer RJ
J Clin Oncol; 2004 Feb; 22(3):464-7. PubMed ID: 14752068
[TBL] [Abstract][Full Text] [Related]
39. Management of testicular seminoma. Our experience.
Sperlongano P; Pisaniello D; Di Mauro U; Pone D; Casoli E
Ann Ital Chir; 2000; 71(1):127-30. PubMed ID: 10829535
[TBL] [Abstract][Full Text] [Related]
40. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
